V132 vaccine study for healthy older adults
Treatments studied
This trial tests a new vaccine called V132 in healthy older people. It aims to see if the vaccine is safe and how the body responds to it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in generally good health
- You are an older adult
- Your body mass index (BMI) is between 18 and 35
- You have not had a pneumococcal infection in the last 3 years
- You have not received a pneumococcal polysaccharide vaccine in the last 10 years
- You have never received a pneumococcal conjugate vaccine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether a new vaccine called V118E is safe and well-tolerated in healthy people. It is for adults who are in good health and have not recently had a pneumococcal infection.
This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.
This study tests a new pneumococcal vaccine (PCV26) for safety in adults 60 and older. It aims to find out if the vaccine is safe and how the body responds to it.
This study tests a new pneumococcal vaccine (PCV15) to see how well it protects against carrying the bacteria that can cause pneumonia. Healthy adults aged 18–50 who have not had a pneumococcal vaccine in the last 5 years may join.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
This trial tests a newer pneumonia vaccine (PCV21) in older veterans with weakened immune systems who have already received an older pneumonia vaccine (PPSV23). It aims to see if the new vaccine provides better protection.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.